March 23, 2020 / 6:43 AM / 15 days ago

BRIEF-SSY Group Gets Approval For Drug Production & Registration For Ropivacaine Hydrochloride Injection

March 23 (Reuters) - SSY Group Ltd:

* GOT APPROVAL FOR DRUG PRODUCTION & REGISTRATION FOR ROPIVACAINE HYDROCHLORIDE INJECTION IN FORM OF POLYPROPYLENE AMPOULE FROM NMPA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below